Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139

Clinical trial NCT02362464 · COMPLETED

Trial details

NCT number: NCT02362464
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostatic Neoplasms Neoplasms of Prostate Prostate Cancer Cancer Of Prostate Stage D0 Prostate Cancer

Start date: 2015-05-12
Primary completion: 2022-03-25
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.